United States· US:65162-512_6b990a95-3932-4771-adb1-84bfe4c456de

Salsalate

A salsalate product containing salsalate, registered in United States by Amneal Pharmaceuticals LLC.

ATC N02BA06US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedSalsalateATCN02BA06REGISTER NO.US:65162-512_6b990a95…PACKS LISTED6CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
SALSALATE
Manufacturer
Amneal Pharmaceuticals LLC
Country
United States (US)
ATC code
N02BA06
ATC class
Salsalate
Defined daily dose
3 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 6

  • ndc11
    65162-512-10
  • ndc11
    65162-512-11
  • ndc11
    65162-512-50
  • ndc11
    6516251210
    100 TABLET in 1 BOTTLE (65162-512-10)
  • ndc11
    6516251211
    1000 TABLET in 1 BOTTLE (65162-512-11)
  • ndc11
    6516251250
    500 TABLET in 1 BOTTLE (65162-512-50)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

161 interactions on record for salsalate.

Graded by severity as the source publishes them — 26 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Salsalate · interactions on record

161 records

  • 26 severe
  • 128 moderate
  • 7 minor

Most severe, free to view

  • MethotrexateL01BA01severe
  • TemsirolimusL01EG01severe
  • EverolimusL01EG02severe
  • SirolimusL01EG04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/57e86b06-f288-430e-bc56-2a30dec708ef
GET /v1/drugs/57e86b06-f288-430e-bc56-2a30dec708ef?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "500",
  "substance": "SALSALATE",
  "productndc": "65162-512",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": null,
  "marketing_category": "UNAPPROVED DRUG OTHER"
}

See everything about salsalate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.